Published in Ann Oncol on January 01, 2004
Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection? Eur Radiol (2006) 1.07
Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancer. Nat Rev Clin Oncol (2009) 0.80
Familial breast cancer screening: ethical and social implications. Ann Oncol (2004) 0.75
Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation (1999) 3.71
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet (2004) 1.33
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis. Ann Oncol (2009) 1.30
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18
Exercise training intervention after coronary angioplasty: the ETICA trial. J Am Coll Cardiol (2001) 1.16
Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Clinical and prognostic implications. Circulation (1995) 1.06
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer. Hum Mutat (2001) 1.01
Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy. Circulation (1998) 1.00
Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients. Br J Cancer (2011) 0.96
Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity. Br J Cancer (2003) 0.94
Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding study. Oncol Rep (2006) 0.85
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study. Oncol Rep (2010) 0.85
Cervical sarcoma botryoides treated with conservative surgery and adjuvant chemotherapy: a case report. Eur J Gynaecol Oncol (2000) 0.84
An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer. Ann Oncol (2004) 0.84
BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models. Ann Oncol (2006) 0.84
Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation. Am J Pathol (1996) 0.83
Cerebral metastasis from ovarian cancer treated with a multidisciplinary approach. Case report and review of literature. Eur J Gynaecol Oncol (2003) 0.83
Effects of exercise training on left ventricular filling at rest and during exercise in patients with ischemic cardiomyopathy and severe left ventricular systolic dysfunction. Am Heart J (1996) 0.82
Tsukamurella tyrosinosolvens and Rhizobium radiobacter sepsis presenting with septic pulmonary emboli. Clin Microbiol Infect (2011) 0.82
P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer. Oncol Rep (2002) 0.81
Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer. Tumori (2001) 0.81
Bone demineralization induced by cementless alumina-coated femoral stems. J Arthroplasty (1994) 0.80
p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumours. Clin Endocrinol (Oxf) (1999) 0.80
Ductal breast carcinoma metastatic to the vulva: a case report. Eur J Gynaecol Oncol (2001) 0.80
Arthroplasty in the ankylotic hip. Chir Organi Mov (1995) 0.80
Prognostic value of p53 molecular status in high-risk primary breast cancer. Ann Oncol (2003) 0.79
Temporal dissociation in the exposure times required for maximal induction of cytotoxicity, mutation, and transformation by N-methyl-N'-nitro-N-nitrosoguanidine in the BALB/3T3 ClA31-1-1 cell line. Cancer Res (1984) 0.78
[Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma?]. Tumori (2003) 0.77
[Clinical guidelines for the management of gastrointestinal stromal tumors]. Clin Ter (2006) 0.77
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study. Br J Cancer (2004) 0.77
Exercise training for patients with chronic heart failure reduced mortality and cardiac events and improved quality of life. West J Med (2000) 0.77
Pelvic relapses in ovarian cancer. Role of CA-125, transvaginal ultrasound and color Doppler. Eur J Gynaecol Oncol (2003) 0.76
Hypersensitivity reaction to carboplatin: successful resolution by replacement with cisplatin. Eur J Gynaecol Oncol (2002) 0.76
Progressive form of multiple pterygium syndrome in association with nemalin-myopathy: report of a female followed for twelve years. Am J Med Genet (1987) 0.76
Indications and limits of acetabular reimplantations using screwed prostheses. Chir Organi Mov (1995) 0.76
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study. Br J Cancer (2005) 0.76
[The adjuvant therapy of colonic carcinoma in old age]. Minerva Med (2000) 0.76
Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603). Lung Cancer (2010) 0.76
Comment on 'Cancer genetic counselling' by P. Mandich et al. (Ann Oncol 2005; 16: 171). Ann Oncol (2005) 0.75
67Ga scanning for evaluating activity in interstitial lung diseases. J Nucl Med Allied Sci (1988) 0.75
[Local analgesia in the mother: effects on the erythrocytes of the newborn infant]. Ric Clin Lab (1989) 0.75
[The diagnosis of hepatic metastases is a frequent problem in clinical practice (author's transl)]. Radiol Med (1980) 0.75
From adjuvant to preventive breast cancer treatment: bridging the gap over troubled waters. Ann Oncol (2006) 0.75
[Cervical maturation. Physiologic aspects and pharmacologic implications]. Minerva Ginecol (1989) 0.75
[Tamoxifen and breast cancer: is everything known already?]. Tumori (1999) 0.75
[Oxaliplatin: preclinical in vitro studies]. Tumori (2002) 0.75
[Clinical usefulness of captopril in the treatment of severe myocardial insufficiency in childhood]. Minerva Cardioangiol (1987) 0.75
[Familiarity and heredity of tumors in function of an early surgical therapeutic approach]. Suppl Tumori (2002) 0.75
[Weekly administration of paclitaxel: peculiarity and biological premises]. Tumori (2001) 0.75
[Use of an animal model in the study of changes in erythrocyte deformability caused by breast cancer]. Minerva Ginecol (1991) 0.75
"Venous hemofiltration associated with loco-regional chemotherapy in the treatment of patients with liver neoplasm". Biomater Artif Cells Immobilization Biotechnol (1993) 0.75
[Health promotion and computer science in radiation protection]. G Ital Med Lav Ergon (2008) 0.75
[Scintigraphic results obtained in the study of neoplasms of the central nervous system with various radio-compounds]. J Radiol Electrol Med Nucl (1975) 0.75
[Malformations in children of diabetic mothers. Etiopathogenetic aspects and strategy of prevention]. Minerva Ginecol (1988) 0.75
[Colposcopic monitoring of primary chemotherapy in patients with locally advanced cancer of the uterine cervix]. Minerva Ginecol (1997) 0.75
[Effects of estradiol on in vitro cultures of human fibroblasts]. Minerva Ginecol (1992) 0.75
[Validity of nuclear magnetic resonance in gynecologic and obstetric diagnosis]. Minerva Ginecol (1988) 0.75
[Malignant gynecologic neoplasms during menopause. Authors' experience]. Minerva Ginecol (1995) 0.75
[Angioscintigraphy with MISA Tc99m and selective angiography in renal expansive processes]. Helv Chir Acta (1977) 0.75
[Injectable progesterone in hormone replacement therapy in menopause]. Clin Ter (1999) 0.75
[Can age influence the course of pregnancy? Experience in the L'Aquila area in the period 1979-1986]. Minerva Ginecol (1988) 0.75
[Labor-determining factors. Study of myometrial receptors and our hypothesis of clinical approach]. Minerva Ginecol (1988) 0.75
[Synchronous associations of tumors in the pelvic organs of the female genital tract]. Minerva Ginecol (1992) 0.75
Surgical treatment of invasive carcinoma of the vulva. Our experience. Eur J Gynaecol Oncol (2000) 0.75
[Statistical report on the births at the Obstetrical and Gynecologic Clinic of L'Aquila during the period 1979-1986]. Minerva Ginecol (1988) 0.75
[Bacterial vaginosis during chemotherapy for gynecological neoplasms. A therapeutic proposal]. Minerva Ginecol (1995) 0.75
[Effects of somatostatin of plasma levels of glucose, insulin and growth hormone in acromegaly]. Minerva Med (1976) 0.75